Andreessen Horowitz is a venture capital firm specializing in investing in seed, start-ups, early, mid-stage, growth, and late-stage. It prefers to invest in the social media business and technology sector with a focus on software, back-end infrastructure, the infrastructure of the Internet, cloud computing, enterprise software and services, consumer, business Internet, mobile-Internet, consumer Internet, cloud computing, data storage, social network browsers data-storage, consumer electronics, networking functions, software related biology, biotech, and medicine companies at the intersection of computer science and life sciences with a focus on digital therapeutics, cloud technology in biology, and computational medicine.

Andreessen Horowitz

Refactor is a seed-stage VC firm investing in bio, climate, and hard tech startups run by Zal Bilimoria. Zal was a partner at a16z and PM for a decade at Google, Netflix, and LinkedIn. He led the seed rounds of Solugen, Astranis, and many other hard tech startups. He is the only decision maker at the firm, writing $1-2M checks in pre-seed and seed rounds.

Refactor

Costanoa Ventures leads Formation, Seed, and Series A stage investments in companies that change the way the world does business.

Costanoa Ventures

Olive Capital (OC) is an early-stage investment firm focused on the tech and synthetic biology sectors. Our portfolio includes diverse companies in these spaces, including Pardes (NASDAQ: PRDS), Akasa, Science, Substack, Ender, Orchid Health, and Rewind. OC builds on the experience of founding partner Olivia Wang, who previously headed up the US office of ZhenFund, managing an AUM of $2 billion and a portfolio of 40+ companies. The combination of our vast VC network and strong founder relationships grants us access to highly competitive investment rounds, to the extent that we are often the sole small fund alongside institutional heavyweights. We take firm evaluation and selection very seriously, pairing in-house research with the expertise of external domain advisors and institutional partners. OC Fund I launched in 2021, and OC Fund II is currently in the pipeline.

Olive Capital

Bond is a venture capital firm that supports visionary founders of high-growth Internet companies throughout their life cycle of innovation and growth. The firm, a spinout of the Kleiner Perkins Digital Growth Fund, was launched in January 2019 and founded by Mary Meeker with Mood Rowghani, Noah Knauf.

Bond

Cube is the family office founded by the Rancilio family in 2013, after the sale of the espresso machine company founded in 1927 by our grandfather Roberto. The Rancilio family managed its company for three generations, during the course of which it became a leading global espresso producer. After selling the family business, we created Rancilio Cube. Cube focuses on venture, growth and impact investments, and makes both direct and fund investments. With regard to direct investments, we invested in companies such as Lyft (made in 2015, we consider it as our ''cornerstone'' venture/growth investment), Sennder, N26, SpaceX, Airbnb, Wise, 23andme, Uber, Flexport, Deliveroo, SumUp, Capsule, Coursera, Lyst, Omaze, Prodigy Finance, Taboola, Applause, Reef, Rapyd, Logz.io, Tier, Toast, Bnext, Treedom, Casavo and many more.  Cube also makes limited partner investments in international VC funds: examples include Pelion, Earlybird DE, Cherry Venture, Foundation Capital, Khosla, NEA, Lake Star, Hoxton Venture, Hetz, Glilot, Cavalry, Bessemer, Omega, Blue Lion, TCV, Firstmark, Seedcamp, Holtzbrinck, OWL, Better Tomorrow, Zetta, DST, Jackson Square Venture, GSquared, Speedinvest, Target GlobaI, Aspect Ventures, Oxford Science Innovation, Triodos Organic Growth and other funds. From 2022 we are a fully compliant investment company for professional investors. We got an embedded global network, with a particularly deep and wide set of relationships in the Us/European investment and corporate markets. Cube goes out of its way to open up its networks for the benefit of the companies and funds in which it has invested.

Rancilio Cube Sicaf

AKASA

AKASA is the leading developer of AI-powered automation for the revenue cycle.  We deliver comprehensive automation for complex workflows. This helps healthcare providers improve revenue outcomes, achieve greater efficiency, elevate their teams, and allocate resources where they matter most. From prior authorization to claims processing, we provide innovative and reliable revenue cycle solutions that give providers peace of mind. AKASA applies advanced technology (such as AI and LLMs) to automate revenue cycle tasks that are complex and time-consuming, and were previously un-solvable at scale. Our solutions are built on deep revenue cycle expertise, grounded in the highest standards for data security, and provide measurable results with accuracy, speed, and completeness. We’ve helped healthcare providers decrease A/R days by 13%, increase efficiency by 86%, save 300+ hours of staff time per month, and increase gross yield by $30M.  With investors that include Andreessen Horowitz, BOND, Costanoa Ventures, and more, we’ve raised more than $200M to help eliminate the financial complexity of healthcare. We’re rebuilding the healthcare revenue cycle with AI.

AKASA is a healthcare technology company that leverages advanced generative AI and machine learning models to address administrative inefficiencies and financial challenges in the revenue cycle management (RCM) process. Their AI solutions are specifically trained on vast amounts of clinical and financial data to comprehend the nuances of the healthcare industry.

Generative AI for Healthcare and Revenue Cycle

Say hello to AKASA

Generative AI powering the AKASA Platform

Using Intelligent Automation to Improve Healthcare Operations

Simplifying healthcare administration with intuitive tech tools

Hospital Management

AI Express, Akasa rip premium seats even as no-frills IndiGo adds business class

AKASA is a healthcare technology company that leverages advanced generative AI and machine learning models to address administrative inefficiencies and financial challenges in the revenue cycle management (RCM) process. Their AI solutions are specifically trained on vast amounts of clinical and financial data to comprehend the nuances of the healthcare industry.
AKASA's platform is powered by large language models and generative AI capabilities akin to ChatGPT, but optimized and tailored for the healthcare domain. Their AI understands clinical context, grasps the intricate details of health systems, and is designed to integrate directly into staff workflows, enabling automation of routine tasks and improving operational efficiencies.
The company takes an "expert-in-the-loop" approach called Unified Automation, which combines machine learning with human expertise. This allows their technology to adapt to the dynamic nature of revenue cycle operations while benefiting from the judgement of AKASA's in-house team of RCM veterans with an average of over 15 years of industry experience.
AKASA's solutions aim to reduce the substantial administrative waste associated with billing and insurance communication failures, estimated at over USD 500 billion annually in the USD 4 trillion healthcare industry. By automating comprehensive and complex tasks, AKASA enables healthcare providers to reallocate staff toward patient-facing activities and enhance care delivery.

Modernizing Medicine is a healthcare technology company that specializes in developing cloud-based electronic health record (EHR) systems and solutions tailored for specific medical specialties. Their flagship products, EMA and gGastro EHR, are designed to streamline clinical workflows and documentation processes, saving time for healthcare providers. These intuitive platforms incorporate built-in medical knowledge and can adapt to individual practice preferences.
Beyond EHRs, Modernizing Medicine offers an integrated suite of products and services, including practice management, revenue cycle management, endoscopy report writing, analytics, and advisory services. Their solutions aim to address the challenges of value-based care, such as population health management, quality measure reporting, and optimizing reimbursements.
Modernizing Medicine's innovative EHR architecture emphasizes speed, convenience, and adaptability, enabling doctors to complete exams efficiently. The systems can generate notes, suggest codes, and automate billing processes, reducing administrative burdens.
In November 2022, Modernizing Medicine agreed to pay USD 45 million to resolve allegations of accepting and paying illegal kickbacks, as well as causing users to report inaccurate information for federal incentive payments. The settlement addressed three marketing programs alleged to have violated the False Claims Act and the Anti-Kickback Statute.

Modernizing Medicine

Kyruus Health is a leading provider of care access solutions that connect patients with the right healthcare providers. The company's platform integrates comprehensive provider data, enabling informed decisions and seamless access to care across various touchpoints. Kyruus Health's offerings include provider search and scheduling tools, cost transparency solutions, and data management capabilities.
Kyruus Health's technology facilitates provider matching, appointment scheduling, and digital patient intake processes. The platform enhances the overall patient experience by streamlining access to care and ensuring transparency regarding provider expertise, availability, and costs. Additionally, Kyruus Health's solutions empower healthcare organizations, such as hospitals, medical groups, and health plans, to optimize provider utilization and comply with industry mandates.
Through strategic acquisitions and partnerships, Kyruus Health has expanded its network to encompass over 425,000 providers across more than 1,000 hospitals and 500 medical groups. As of 2023, the company served over 90 million health plan members from 100 different health plan brands, solidifying its position as a leading care access platform.
Key customers and partnerships
In July 2024, Kyruus Health announced a strategic partnership with XO Health, an innovative healthcare services organization designed for self-insured employers. This collaboration aimed to enhance XO Health's digital member experience by integrating Kyruus Health's provider search and cost transparency tools, ultimately creating a seamless healthcare journey for members, providers, and payers.
Furthermore, in May 2024, Kyruus Health expanded its national provider network by integrating virtual behavioral health providers, demonstrating its commitment to improving access to mental health services. This expansion added over 30,000 virtual behavioral health providers to the Kyruus Network, enabling health plans, hospitals, and medical groups to seamlessly integrate these providers into their online directories and address access gaps.
Kyruus Health also partnered with WellHive and V3 Gate to support the Veterans Health Administration (VHA), aiming to improve care for all Veterans by accelerating access to care through centralized appointment management across VHA sites.

Kyruus

XSOLIS is an AI technology company that offers a platform and solutions to create a more efficient healthcare system by facilitating improved communication and alignment between healthcare providers and payers. The company's flagship product, CORTEX, is an AI-driven platform that utilizes real-time predictive analytics to continuously assign an objective medical necessity score and assess the anticipated level of care for every patient. This technology aims to eliminate waste by leveraging data science, automation, transparency, and objective insights to ensure appropriate care settings.
XSOLIS's solutions streamline patient status communications, enabling providers and payers to align on medical necessity, length of stay timelines, and appropriate care levels. The platform's AI capabilities enable the creation of live clinical profiles for each patient, recognizing patterns to generate predictive analytics for determining the most suitable care setting. CORTEX reduces the administrative burden of case reviews through its proprietary Care Level Score (CLS), allowing teams to prioritize discharge planning tasks and driving optimal workflows.
By August 2022, XSOLIS achieved a three-year revenue growth of 388%, ranking No. 1795 on the 2022 Inc. 5000 list of America's fastest-growing private companies. The company reported 111% growth in its payer network and a 44% increase in hospital partnerships in the same year.

XSOLIS

Suki AI is a healthcare technology company that develops an AI-powered voice assistant, Suki Assistant, designed to help clinicians complete administrative tasks efficiently. The Suki Assistant utilizes natural language processing and generative AI to transcribe conversations between clinicians and patients into clinical notes, populating electronic health records (EHRs) with relevant data. By automating documentation, the company aims to reduce the time clinicians spend on paperwork, claiming to shrink it by as much as 72% in family medicine settings.
Suki Assistant offers multiple modes, including ambient note generation, dictation, and voice commands. The ambient mode leverages generative AI to listen to clinician-patient interactions and auto-generate clinical notes in real-time without human intervention. Clinicians can accept, reject, or edit the AI-generated content to ensure accuracy. In addition to documentation, Suki Assistant can retrieve patient information, such as medication lists and allergies, from EHRs and provide diagnosis code recommendations.
Suki Assistant is deeply integrated with major EHR systems, including Epic, Cerner, athenahealth, Elation, and Meditech, enabling bidirectional synchronization of notes and codes. The company expanded its capabilities to support inpatient care settings in October 2023, making it the first AI-powered voice solution tailored for clinicians in hospitals. Suki Assistant operates across various platforms, including iOS, Android, web, Windows, Mac, and as a Chrome extension.
In October 2023, Suki announced the acquisition of an undisclosed company to enhance its personalization features, allowing the assistant to adapt to individual user preferences and existing workflows.

Suki

Platforms used by hospitals to manage the various aspects of patient care to improve overall efficiency, such as automating routine tasks, improving communication and coordination among healthcare providers, and enhancing patient outcomes within the hospital setting

Platforms that enable patients to actively participate in their healthcare journey by educating and engaging them, along with improving communication with healthcare providers

Platforms that help healthcare organizations analyze patient data and other performance metrics to improve decision-making and optimize resource allocation

Platforms that are designed to help hospitals and health systems manage their financial operations from patient billing and insurance claims to revenue tracking and analysis

AI-powered software solutions that are designed to help healthcare organizations streamline and automate the process of documenting patient encounters

Companies that use GenAI as a core part of their product offering for hospital management

Offers software platforms that streamline and improve hospital operations

AI/ML algorithms optimize workflows, enable predictive modeling, and analyze patient data in healthcare

Hospital Management companies use GenAI to manage and automate administrative tasks, offering a range of tech solutions designed to meet the needs of different departments and functions.

IoT medical solutions turn traditional hospitals into smart hospitals, allowing them to streamline workflows

AKASA

Sources

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless